Logo

Lyn Rees, Stephen Little, Keng Hsu

Jul 06, 2018

Lyn Rees has become CEO of Premaitha Health, replacing Stephen Little, who is now the company's executive vice chairman. Rees joins Premaitha from BBI Group, where he was most recently CEO.

In addition, Keng Hsu has become Premaitha's chief operating officer for Asia. He used to be CFO of Yourgene Bioscience, which Premaitha acquired last year.

Furthermore, Alan Chang has stepped down as non-executive director of Premaitha to focus on other business interests.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.